IDH-mutated diffuse grade III astrocytoma
Showing 1 - 25 of >10,000
Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant Trial in Oslo (Radiation therapy)
Recruiting
- Oligodendroglioma
- +2 more
- Radiation therapy
-
Oslo, NorwayOslo University Hospital
Jan 14, 2022
Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)
Active, not recruiting
- Astrocytoma, IDH-Mutant, Grade 2
- Astrocytoma, IDH-Mutant, Grade 3
- Questionnaire Administration
- +3 more
-
Phoenix, Arizona
- +24 more
Dec 7, 2022
Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)
Active, not recruiting
- Grade III Astrocytoma
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 9, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Supramaximal Resection Versus Maximal Resection for High-Grade
Recruiting
- Glioblastoma
- +11 more
- Supramaximal resection
- Maximal safe resection
-
San Francisco, California
- +7 more
Nov 1, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Astrocytoma, Grade III Trial in San Antonio, Zuerich (Debio 0123,
Not yet recruiting
- Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
- Astrocytoma, Grade III
- Debio 0123
- +2 more
-
San Antonio, Texas
- +1 more
Mar 9, 2023
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes
Recruiting
- Astrocytoma, Grade II
- +3 more
-
Rotterdam, Zuid Holland, Netherlands
- +4 more
Mar 23, 2020
Low-grade Glioma, Temozolomide, Phase III Trial in Worldwide (drug, radiation, procedure)
Terminated
- Low-grade Glioma
- +3 more
- Temozolomide
- +2 more
-
Woolloongabba, Brisbane, QLD, Australia
- +44 more
Jan 31, 2022
Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas
Completed
- Glioma
-
Montpellier, FranceUh Montpellier
Jun 4, 2020
Space Occupying Lesions of the Brain
Recruiting
- Brain Tumor
- +2 more
- MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
-
Bern, SwitzerlandInstitute for Diagnostic and Interventional Neuroradiology, Univ
Jan 26, 2023
Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)
Recruiting
- Recurrent IDH1/2 Mutated Glioma
-
Paris, FrancePitie Salpetriere Hospital
Aug 29, 2022
Glioma Trial in Melbourne (Biopsy, Part A: AB-218, Surgery (maximal resection))
Recruiting
- Glioma
- Biopsy
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Melbourne Hospital
Oct 11, 2022
Clinical Development of Cancer-Specific MRS Biomarkers in
Completed
- Malignant Gliomas
- +2 more
- 3 Tesla scanning
-
Dallas, TexasUT Southwestern Medical Center
Jan 19, 2022
Vascular Habitats Within Astrocytoma Grade 4 at Molecular,
Recruiting
- Astrocytoma, Grade IV
- +7 more
-
Valencia, SpainBiomedical Data Science Lab. Universitat Politècnica de València
May 11, 2022
Glioma Trial in Paris (MRI)
Not yet recruiting
- Glioma
- MRI
-
Paris, FrancePitié-Salpetrière Hospital
Jan 27, 2023
Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- Fimepinostat
- Therapeutic Conventional Surgery
-
Los Angeles, California
- +18 more
Aug 16, 2022
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,
Not yet recruiting
- Diffuse Astrocytoma, IDH-Mutant
- +20 more
- NEO212 Oral Capsule
- +8 more
- (no location specified)
Sep 18, 2023
Astrocytoma, Grade III Trial in Orange (NOVOTTF-200A)
Recruiting
- Astrocytoma, Grade III
- NOVOTTF-200A
-
Orange, CaliforniaUniversity of California, Irvine
Feb 19, 2021
Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, High Grade Glioma Trial run by the NCI (Lenalidomide, XRT, 54-59.4 Gy)
Completed
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Lenalidomide
- XRT, 54-59.4 Gy
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 30, 2021
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022